July 8, 2021
|
July 20, 2021
|
November 10, 2021
|
July 12, 2021
|
February 1, 2022 (Final data collection date for primary outcome measure)
|
Decisional conflict [ Time Frame: Time of survey (2 days-2 weeks after treatment for acute appendicitis) ] Validated evaluation of decision making
|
Same as current
|
|
Preparation for decision making [ Time Frame: Time of survey (2 days-2 weeks after treatment for acute appendicitis) ] Validated measure for patient subject preparedness to make a treatment decision
|
Same as current
|
Not Provided
|
Not Provided
|
|
Appendicitis Choice of Treatment Study
|
Appendicitis Choice of Treatment Study
|
A longitudinal observational/survey study evaluating patient centered decision making in the choice of treatment for acute appendicitis. Survey evaluates patients experience with decision making and the types of decision support they receive.
|
Not Provided
|
Observational
|
Observational Model: Case-Only Time Perspective: Prospective
|
Not Provided
|
Not Provided
|
Non-Probability Sample
|
Patients presenting to the emergency department with acute appendicitis who are considered to be candidates for operative or nonoperative management by the treating clinical team. Patients can ultimately have undergone either treatment.
|
Acute Appendicitis
|
Other: Patients with acute appendicitis
No intervention, single survey
|
Patients with acute appendicitis
Intervention: Other: Patients with acute appendicitis
|
Not Provided
|
|
Recruiting
|
40
|
Same as current
|
February 1, 2022
|
February 1, 2022 (Final data collection date for primary outcome measure)
|
Inclusion Criteria:
- English Speaking
- Diagnosed with acute appendicitis
- Considered by the treating clinical team to be eligible for treatment with surgery or with non operative treatment (antibiotics)
- Access to an internet connected device capable of taking the survey
Exclusion Criteria:
- Patients who do not make their own medical decisions
- Patients who are not felt to be candidates for a decision between operative and nonoperative treatment by the treating clinical team
- Under 18 years of age
|
Sexes Eligible for Study: |
All |
|
18 Years and older (Adult, Older Adult)
|
Yes
|
Contact: Joshua Rosen, MD, MHS |
206-616-6577 |
jerosen@uw.edu |
|
Contact: Shalynn Howard, MA |
|
shahow@uw.edu |
|
|
United States
|
|
|
NCT04968782
|
STUDY00013390
|
No
|
Studies a U.S. FDA-regulated Drug Product: |
No |
Studies a U.S. FDA-regulated Device Product: |
No |
|
Plan to Share IPD: |
Undecided |
|
David Flum, University of Washington
|
University of Washington
|
Not Provided
|
Study Director: |
David R Flum, MD, MPH |
University of Washington |
|
University of Washington
|
November 2021
|